Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hollis

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Stem Cell Reports|November 13, 2020
β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion ProductionJiaying Han, Kevin Tam, Feiyang Ma, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell diseaseKevyn L Hart, Boya Liu, Devin Brown, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell DiseaseValentina Poletti, Fabrizia Urbinati, Sabine Charrier, et al.
Human Gene Therapy|September 11, 2018
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison StudyFabrizia Urbinati, Beatriz Campo Fernandez, Katelyn E Masiuk, et al.
Molecular Therapy. Nucleic Acids|January 30, 2017
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted EndonucleasesCarmen F Bjurström, Michelle Mojadidi, John Phillips, et al.
Experimental Hematology|February 15, 2015
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cellsFabrizia Urbinati, Phillip W Hargrove, Sabine Geiger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2017
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor CellsJoseph Long, Megan D Hoban, Aaron R Cooper, et al.
Blood|November 4, 2022
Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expressionRyan L Wong, Sarah Sackey, Devin Brown, et al.
Cancer Research|July 20, 2014
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized miceEric H Gschweng, Melissa N McCracken, Michael L Kaufman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 5, 2008
Modelling the interaction of haemodynamics and the artery wall: current status and future prospectsP V Lawford, Y Ventikos, A W Khir, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Stem Cell Reports|November 13, 2020
β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion ProductionJiaying Han, Kevin Tam, Feiyang Ma, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell diseaseKevyn L Hart, Boya Liu, Devin Brown, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell DiseaseValentina Poletti, Fabrizia Urbinati, Sabine Charrier, et al.
Human Gene Therapy|September 11, 2018
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison StudyFabrizia Urbinati, Beatriz Campo Fernandez, Katelyn E Masiuk, et al.
Molecular Therapy. Nucleic Acids|January 30, 2017
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted EndonucleasesCarmen F Bjurström, Michelle Mojadidi, John Phillips, et al.
Experimental Hematology|February 15, 2015
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cellsFabrizia Urbinati, Phillip W Hargrove, Sabine Geiger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2017
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor CellsJoseph Long, Megan D Hoban, Aaron R Cooper, et al.
Blood|November 4, 2022
Lentiviral gene therapy for X-linked chronic granulomatous disease recapitulates endogenous CYBB regulation and expressionRyan L Wong, Sarah Sackey, Devin Brown, et al.
Cancer Research|July 20, 2014
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized miceEric H Gschweng, Melissa N McCracken, Michael L Kaufman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 5, 2008
Modelling the interaction of haemodynamics and the artery wall: current status and future prospectsP V Lawford, Y Ventikos, A W Khir, et al.
Pageof 11